Search research articles
Contact Us
Filters
Showing results (481-490 of 706) with videos related to
Page
of 71
Sort By:
Circulation
|
September 8, 2017
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up
Antonio J Vallejo-Vaz, Michele Robertson, Alberico L Catapano, et al.
Journal of Clinical Lipidology
|
September 10, 2015
Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit
Jing Pang, Elissa B Poulter, Damon A Bell, et al.
The Medical Journal of Australia
|
July 31, 2020
Coronary artery calcium scoring in cardiovascular risk assessment of people with family histories of early onset coronary artery disease
Prasanna Venkataraman, Tony Stanton, Danny Liew, et al.
American Heart Journal
|
May 15, 2018
Rationale and design of a trial to personalize risk assessment in familial coronary artery disease
Thomas H Marwick, Kristyn Whitmore, Stephen J Nicholls, et al.
The Australian and New Zealand Journal of Psychiatry
|
September 14, 2020
Mental health recovery and physical health outcomes in psychotic illness: Longitudinal data from the Western Australian survey of high impact psychosis catchments
Vera A Morgan, Anna Waterreus, Taryn Ambrosi, et al.
Research in Social & Administrative Pharmacy : RSAP
|
February 9, 2021
Exploring the association between stroke and acute myocardial infarction and statins adherence following a medicines co-payment increase
Karla L Seaman, Max K Bulsara, Frank M Sanfilippo, et al.
Obesity Research
|
June 25, 2005
High-density lipoprotein apolipoprotein A-I kinetics in obesity
Esther M M Ooi, Gerald F Watts, Maryam S Farvid, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
October 13, 2018
Introducing the 'Drucebo' effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions
Peter E Penson, G B John Mancini, Peter P Toth, et al.
Frontiers in Cardiovascular Medicine
|
February 22, 2024
Elevated remnant cholesterol and non-HDL cholesterol concentrations from real-world laboratory results: a cross-sectional study in Southeast Asians
Wann Jia Loh, Heng Samuel Soh, Mon Hnin Tun, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 2, 2015
Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial
Harold Bays, Daniel Gaudet, Robert Weiss, et al.
Page
of 71
Search research articles
Search
Showing results (481-490 of 706) with videos related to
Sort By:
Page
of 71
Circulation
|
September 8, 2017
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up
Antonio J Vallejo-Vaz, Michele Robertson, Alberico L Catapano, et al.
Journal of Clinical Lipidology
|
September 10, 2015
Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit
Jing Pang, Elissa B Poulter, Damon A Bell, et al.
The Medical Journal of Australia
|
July 31, 2020
Coronary artery calcium scoring in cardiovascular risk assessment of people with family histories of early onset coronary artery disease
Prasanna Venkataraman, Tony Stanton, Danny Liew, et al.
American Heart Journal
|
May 15, 2018
Rationale and design of a trial to personalize risk assessment in familial coronary artery disease
Thomas H Marwick, Kristyn Whitmore, Stephen J Nicholls, et al.
The Australian and New Zealand Journal of Psychiatry
|
September 14, 2020
Mental health recovery and physical health outcomes in psychotic illness: Longitudinal data from the Western Australian survey of high impact psychosis catchments
Vera A Morgan, Anna Waterreus, Taryn Ambrosi, et al.
Research in Social & Administrative Pharmacy : RSAP
|
February 9, 2021
Exploring the association between stroke and acute myocardial infarction and statins adherence following a medicines co-payment increase
Karla L Seaman, Max K Bulsara, Frank M Sanfilippo, et al.
Obesity Research
|
June 25, 2005
High-density lipoprotein apolipoprotein A-I kinetics in obesity
Esther M M Ooi, Gerald F Watts, Maryam S Farvid, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
October 13, 2018
Introducing the 'Drucebo' effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions
Peter E Penson, G B John Mancini, Peter P Toth, et al.
Frontiers in Cardiovascular Medicine
|
February 22, 2024
Elevated remnant cholesterol and non-HDL cholesterol concentrations from real-world laboratory results: a cross-sectional study in Southeast Asians
Wann Jia Loh, Heng Samuel Soh, Mon Hnin Tun, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 2, 2015
Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial
Harold Bays, Daniel Gaudet, Robert Weiss, et al.
Page
of 71